Resectable adenocarcinoma developing in the remnant pancreas 7 years after partial pancreatoduodenectomy for invasive ductal adenocarcinoma of the pancreas: a case report

Gastrointestinal Cancer

Multidisciplinary Approach to a Patient with Acinar Cell Carcinoma, a Rare Pancreatic Malignancy

healthbook Times Oncology Hematology

Palmarocchi MC, Merlo E, Cefali M, De Dosso S

doi: 10.36000/hbT.OH.2021.07.029

Gynecologic Cancer

Long-term survival with bevacizumab in heavily pretreated and platinum-resistant mucinous ovarian cancer: A case report

J Obstet Gynaecol Res.

Tarumi Y, Mori T, Matsushima H, Kokabu T, Tsuchiya H, Kitawaki J

doi: 10.1111/jog.13496.

Lymphoma

Nivolumab maintenance after salvage autologous stem cell transplantation results in long term remission in multiple relapsed primary cns lymphoma

Eur J Haematol.

Terziev D, Hutter B, Klink B, Stenzinger A, Stögbauer F, Glimm H, Fröhling S, Wickenhauser C, Jordan K, Hurtz HJ, Müller LP, Rüssel J, Weber T

doi: 10.1111/ejh.13072.

A rare case of esophageal metastasis from pancreatic ductal adenocarcinoma: a case report and literature review

Oncotarget.

Rosati LM, Kummerlowe MN, Poling J, Hacker-Prietz A, Narang AK, Shin EJ, Le DT, Fishman EK, Hruban RH, Yang SC, Weiss MJ, Herman JM

doi: 10.18632/

Gynecologic Cancer

Partial Cystectomy for Atypical Isolated Recurrence of Ovarian Adenocarcinoma - A Case Report and Literature Review

In Vivo.

Bacalbasa N, Balescu I

doi: 10.21873/invivo.11078.

Multiple Myeloma (MM)

Bortezomib before and after high-dose therapy in myeloma: long-term results from the phase III HOVON-65/GMMG-HD4 trial

Leukemia.

Goldschmidt H, Lokhorst HM, Mai EK, van der Holt B, Blau IW, Zweegman S, Weisel KC, Vellenga E, Pfreundschuh M, Kersten MJ, Scheid C, Croockewit S, Raymakers R, Hose D, Potamianou A, Jauch A, Hillengass J, Stevens-Kroef M, Raab MS, Broijl A, Lindemann HW, Bos GMJ, Brossart P, van Marwijk Kooy M, Ypma P, Duehrsen U, Schaafsma RM, Bertsch U, Hielscher T, Jarari L, Salwender HJ, Sonneveld P

doi: 10.1038/leu.2017.211.

LeukemiaLymphoma

Time for a New Standard: Single Agent Ibrutinib shows Long-Term Efficacy and Safety in Previously Treated MCL and CLL^1-4

This healthbook SPECIAL is supported by Janssen-Cilag AG

Gastrointestinal Cancer

Tumour response to TRK inhibition in a patient with pancreatic adenocarcinoma harbouring an NTRK gene fusion

Ann Oncol.

O'Reilly EM, Hechtman JF

doi: 10.1093/annonc/mdz385.

Genitourinary Cancer

Long-term complete remission with Ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients

J Immunother Cancer.

Cabel L, Loir E, Gravis G, Lavaud P, Massard C, Albiges L, Baciarello G, Loriot Y, Fizazi K

doi: 10.1186/s40425-017-0232-7.

Related content